Variables | Group 1 Placebo group (n = 42) | Group 2 Omega 3 group (n = 42) | Group 3 Vitamin D group (n = 42) | Group 4 Vitamin + Omega 3 group (n = 42) | P value¥ | ηp2¥ | ||
---|---|---|---|---|---|---|---|---|
Time | Time* group interaction | time | Time* group interaction | |||||
Vitamin D | − 4.49 (5.03) | − 2.38 (5.28) | 8.27 (7.77) | 9.68 (7.34)# | < .001* | < .001* | .15 | .49 |
FBS (mg/dL) | 2.60 (6.59) | − 6.64 (5.14) | − 3.56 (7.11) | − 9.37 (6.4)ǁ | < .001* | < .001* | .3 | .33 |
Insulin (µIU/mL) | 3.06 (3.69) | − 1.80 (2.16) | 1.92 (3.91) | − 2.61 (1.68)ǁ | .13 | < .001* | .002 | .38 |
HOMA-IR | 0.83 (1.05) | − 0.58 (0.51) | 0.40 (1.05) | − 0.85 (0.48) | .04* | < .001* | .004 | .42 |
HOMA-B | 0.28 (0.53) | − 0.002 (0.42) | 0.27 (0.4) | − 0.04 (0.31)ǁ | < .001* | < .001* | .08 | .19 |
Triglycerides (mg/dL) | 10.81 (54.27) | − 15.48 (40.02) | 3.27 (56.55) | − 22.32 (34.58) | < .001* | < .001* | .01 | .07 |
Total-cholesterol (mg/dL) | − 4.21 (22.71) | − 14.29 (26.8) | − 10.23 (29.89) | − 22.74 (29.7) | < .001* | < .001* | .18 | .006 |
HDL-C (mg/dL) | − 0.32 (3.74) | 0.82 (5.35) | 0.4 (5.15) | 1.29 (5.68)ǁ | < .001* | .004* | .01 | .01 |
LDL-C (mg/dL) | − 4.12 (20.58) | − 11.53 (25.52) | − 10.29 (26.40) | − 19.04 (29.03) | < .001* | < .001* | .16 | .04 |
Weight | 0.31 (1.03) | − 0.06 (1.42) | 0.06 (1.27) | − 0.36 (1.65)ǁ | .77 | < .001* | 0 | .03 |
BMI | − 0.002 (0.54) | − 0.07 (0.81) | − 0.036 (0.63) | − 0.05 (0.68) | .04 | .63 | .004 | .002 |
Waist circumference | − 0.01 (1.7) | − 0.84 (1.77) | − 0.43 (1.8) | − 1.15 (2.23)ǁ | < .001* | < .001* | .09 | .05 |